URL | Priority | Change frequency | Last modified (GMT) |
---|---|---|---|
https://alzheon.com/alzheon-reports-industry-leading-disease-modifying-effects-from-phase-2-biomarker-trial-of-oral-tablet-alz-801-valiltramiprosate-in-patients-with-early-alzheimers-disease/ | 60% | Monthly | 2022-02-09 21:04 |